Shares of Natco Pharma saw a notable rise of over 2%, reaching an intraday high of ₹1,435.40, as investors eagerly anticipate the company’s upcoming Q2 FY25 results.
The stock opened at ₹1,402.00 and has been fluctuating within a tight range, with a 52-week high of ₹1,639.00 and a low of ₹752.45. The positive momentum is driven by market expectations of strong performance, further bolstering investor confidence in the pharmaceutical company’s prospects.
As of 10:55 am, Natco Pharma shares were trading 2.13% higher at Rs 1,425.00 on the NSE.
Disclaimer: The information provided is for informational purposes only and should not be considered financial or investment advice. Stock market investments are subject to market risks. Always conduct your own research or consult a financial advisor before making investment decisions. Author or Business Upturn is not liable for any losses arising from the use of this information.
